¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ ÃֽŠÀÇ°úÇÐºÐ¾ß ÅëÇÕ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 

ÃֽŠÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®

 

10¿ù ÀÇ°úÇÐºÐ¾ß ÅëÇÕ ¿¬±¸µ¿Çâ Å°¿öµå ¹× ³×Æ®¿öÅ© ºÐ¼®



 

                        ±×¸² 1.   ÀÇ°úÇÐ 10¿ù ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå






 

Ç¥ 1. ÀÇ°úÇÐ ÅëÇÕ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå(N=2,787)  

Å°¿öµå ¼øÀ§

±¹³» ÀÇ°úÇÐ ¿¬±¸µ¿Çâ 

±¹¿Ü ÀÇ°úÇÐ ¿¬±¸µ¿Çâ

ÀÇ°úÇÐ ¿¬±¸µ¿Çâ 

1

Women

Risk

Risk

2

COVID-19

Genes

Neoplasms

3

Pediatrics

Neoplasms

Genes

4

Risk

Attention

Women

5

Older Adults

General Surgery

Attention

6

Pain

Economics

COVID-19

7

Exercise

Role

General Surgery

8

General Surgery

Women

Economics

9

Depression

Humans

Humans

10

Neoplasms

COVID-19

Role

 

 

 

 

                 ±×¸² 2. ÀÇ°úÇÐºÐ¾ß ÅëÇÕ ¿¬±¸µ¿Çâ Å°¿öµå ³×Æ®¿öÅ© ºÐ¼® 







 

Ç¥  2. ÀÇ°úÇР 10¿ù ÅäÇÈ ³×Æ®¿öÅ© ¸ðµ¨¸µ   

Topic1

Topic2

Topic3

Topic4

Topic5

Attention

COVID-19

Depression

Stability

Humans

Genes

Risk

Pediatrics

F-18 Fdg Pet

Neoplasms

Environment

Stroke

Behavior

Pain

Role

Economics

Mortality

Women

General Surgery

Genes

Efficiency

Women

Risk

Bone And Bones

Attention

Learning

Vaccination

Older Adults

Sensitivity And Specificity

Liver

Humans

Diabetes

Family

Recurrence

Brain

Water

Population

Adolescent

Complication

Inflammation

Dataset

Drug

Smoking

Survival Rate

Drug

Technology

Death

Education

Neoplasms

Serum

 




 

±×¸² 3.   ÀÇ°úÇÐºÐ¾ß ÅëÇÕ  Å°¿öµå ÃßÃâ  ¸ðµ¨¸µ ³×Æ®¿öÅ©  ºÐ¼®



 

ÀÇ°úÇÐ ºÐ¾ß ÅëÇÕµÈ ¿¬±¸µ¿Ç⠺м®¿¡ »ç¿ëµÈ ³í¹® µ¥ÀÌÅÍ´Â Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ ±¹³» Àú³Î°ú ±¹Á¦ Àú³ÎÀ» ÅëÇØ  ¹ßÇ¥µÈ ³í¹® Áß¿¡¼­ Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿Í ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)ÀÇ Æà¸Þµå(PubMed) µ¥ÀÌÅͺ£À̽º¿¡ Àε¦½ÌµÈ ³í¹® µ¥ÀÌÅ͸¦ »ç¿ëÇÏ¿´´Ù. ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿Ç⠺м®¿¡¼­´Â COVID-19, Risk, General Surgery µîÀ» Áß½ÉÀ¸·Î ÇÑ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ¸ðµ¨¸µÀ» Çü¼ºÇÏ¿´À¸¸ç, ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå´Â Risk, Neoplasms, Genes, Women, Attention, COVID-19, General Surgery, Economics, Humans, Role, Pediatrics, Drug, Pain, Sensitivity & Specificity, Mortality, Older Adults, Depression, Population, Survival Rate µîÀ¸·Î ³ªÅ¸³µ´Ù. 

±¹³»¿Ü Àú³ÎÀ» ÅëÇÏ¿© 10¿ù¿¡ ÀÇ°úÇко߿¡ ¹ßÇ¥µÈ ³í¹® °Ç¼ö´Â ÃÑ 2,787ÆíÀ¸·Î ³ªÅ¸³ª ÀÌ´Â Àü¿ù¿¡ ºñ±³ÇÏ¿© 531Æí °¨¼ÒÇÑ Ãß¼¼·Î ³ªÅ¸³µ´Ù. ÀÌ °¡¿îµ¥ ±¹³» Àú³ÎÀ» ÅëÇÑ ¹ßÇ¥´Â 926ÆíÀÌ°í, ±¹Á¦ Àú³ÎÀ» ÅëÇÑ ¹ßÇ¥´Â 1,861ÆíÀ¸·Î ³ªÅ¸³ª ÇØ¿Ü Àú³ÎÀ» ÅëÇÑ ³í¹® ¹ßÇ¥°¡ Áö¼ÓÀûÀ¸·Î ¿ùµîÀÌ ³ô°Ô ³ªÅ¸³µ´Ù. ÀÇ°úÇÐ ºÐ¾ßº° ³í¹®¹ßÇ¥ ÇöȲÀ» »ìÆ캸¸é ÀÓ»óÀÇÇÐ 1,218Æí, ±âÃÊÀÇÇÐ 1,018Æí, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ 348Æí, Ä¡ÀÇÇÐ 124Æí, °£È£ÇÐ 79Æí ¼øÀ¸·Î ³ªÅ¸³µ´Ù. 






 

      ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø






 

* º» ³»¿ëÀº MedRIC (www.medric.or.kr)ÀÇ ¿¬±¸µ¿Çâ¿¡¼­ ¼­ºñ½ºµÇ´Â ³»¿ëÀÔ´Ï´Ù.




 

 

 

 


2022-11-16 ¿ÀÈÄ 3:40:03, Á¶È¸¼ö : 524